Genpact (NYSE:G) Sets New 1-Year Low – What’s Next?

Shares of Genpact Limited (NYSE:GGet Free Report) hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $33.80 and last traded at $34.1470, with a volume of 163961 shares. The stock had previously closed at $34.50.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Susquehanna set a $42.00 price objective on Genpact in a report on Friday, February 6th. Mizuho dropped their price objective on Genpact from $51.00 to $49.00 and set a “neutral” rating on the stock in a report on Tuesday, February 10th. Wall Street Zen downgraded shares of Genpact from a “buy” rating to a “hold” rating in a research note on Saturday, March 14th. Needham & Company LLC decreased their target price on shares of Genpact from $53.00 to $50.00 and set a “buy” rating for the company in a research note on Friday, February 6th. Finally, Citigroup upgraded shares of Genpact from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 13th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $47.29.

View Our Latest Stock Analysis on G

Genpact Stock Down 1.6%

The firm has a market cap of $5.76 billion, a price-to-earnings ratio of 10.85, a P/E/G ratio of 1.07 and a beta of 0.74. The firm’s 50 day moving average price is $37.91 and its two-hundred day moving average price is $41.65. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.66 and a quick ratio of 1.66.

Genpact (NYSE:GGet Free Report) last announced its earnings results on Friday, February 6th. The business services provider reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.04. Genpact had a net margin of 10.88% and a return on equity of 22.02%. The business had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.31 billion. During the same quarter in the prior year, the firm earned $0.91 earnings per share. The business’s quarterly revenue was up 5.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Genpact Limited will post 3.6 earnings per share for the current fiscal year.

Genpact Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be given a $0.1875 dividend. The ex-dividend date is Wednesday, June 10th. This represents a $0.75 dividend on an annualized basis and a yield of 2.2%. Genpact’s dividend payout ratio (DPR) is presently 23.96%.

Insider Buying and Selling

In related news, CEO Balkrishan Kalra sold 2,800 shares of the firm’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $40.77, for a total value of $114,156.00. Following the completion of the sale, the chief executive officer owned 525,007 shares in the company, valued at $21,404,535.39. This trade represents a 0.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.58% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Genpact

A number of hedge funds have recently added to or reduced their stakes in G. Royal Bank of Canada lifted its position in Genpact by 19.7% in the first quarter. Royal Bank of Canada now owns 121,705 shares of the business services provider’s stock valued at $6,131,000 after purchasing an additional 20,043 shares during the period. Amundi purchased a new position in Genpact in the first quarter valued at about $58,000. Goldman Sachs Group Inc. increased its holdings in Genpact by 20.8% in the first quarter. Goldman Sachs Group Inc. now owns 353,074 shares of the business services provider’s stock valued at $17,788,000 after buying an additional 60,887 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Genpact by 12.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 511,627 shares of the business services provider’s stock valued at $25,776,000 after buying an additional 56,557 shares in the last quarter. Finally, Focus Partners Wealth increased its holdings in Genpact by 10.3% in the first quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider’s stock valued at $263,000 after buying an additional 488 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.

About Genpact

(Get Free Report)

Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.

Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.

Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.

Featured Articles

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.